Leidos subcontracts malaria vaccine work to Pfenex; GSK nears expanded label for pneumococcal vaccine;

> Leidos has subcontracted part of its NIH malaria vaccine contract to Pfenex. Release

> GlaxoSmithKline ($GSK) is one step closer to expanding the European label for its pneumococcal conjugate vaccine. Item

> Researchers are developing a diagnostic chip to predict whether a vaccine will provide protection. Abstract

> Vietnam is still investigating why three newborns died after receiving hepatitis B vaccines. Article

> Chinese scientists are aiming to introduce a H7N9 vaccine within 6 months. Piece

> Cuba is developing two oral cholera vaccines, one of which is in advanced clinical trials. Post

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.